Abstract
With 28 potential N-glycosylation sites, human carcinoembryonic antigen (CEA) bears an extreme amount of N-linked glycosylation, and approximately 60% of its molecular mass can be attributed to its carbohydrates. CEA is often overexpressed and released by many solid tumors, including colorectal carcinomas. CEA displays an impressive heterogeneity and variability in sugar content; however, site-specific distribution of carbohydrate structures has not been reported so far. The present study investigated CEA samples purified from human colon carcinoma and human liver metastases and enabled the characterization of 21 out of 28 potential N-glycosylation sites with respect to their occupancy. The coverage was achieved by a multienzymatic digestion approach with specific enzymes, such as trypsin, endoproteinase Glu-C, and the nonspecific enzyme, Pronase, followed by analysis using sheathless CE-MS/MS. In total, 893 different N-glycopeptides and 128 unique N-glycan compositions were identified. Overall, a great heterogeneity was found both within (micro) and in between (macro) individual N-glycosylation sites. Moreover, notable differences were found on certain N-glycosylation sites between primary adenocarcinoma and metastatic tumor in regard to branching, bisection, sialylation, and fucosylation. Those features, if further investigated in a targeted manner, may pave the way toward improved diagnostics and monitoring of colorectal cancer progression and recurrence. Raw mass spectrometric data and Skyline processed data files that support the findings of this study are available in the MassIVE repository with the identifier MSV000086774 [DOI: 10.25345/C5Z50X].
| Original language | English |
|---|---|
| Pages (from-to) | 1666-1675 |
| Number of pages | 10 |
| Journal | Journal of Proteome Research |
| Volume | 20 |
| Issue number | 3 |
| Early online date | 9 Feb 2021 |
| DOIs | |
| Publication status | Published - 5 Mar 2021 |
Bibliographical note
Publisher Copyright:© 2021 The Authors. Published by American Chemical Society.
Funding
This study was supported by the European Union (Horizon 2020 Framework Programme; Marie Curie European Training Network, GlyCoCan project, Grant Number 676421 and Seventh Framework Programme HighGlycan and IBD-BIOM, Grant Numbers 278535 and 305479), a grant Spanish Ministry of Economy and Competitiveness (RTI2018-097411-B-I00), a Horizon Programme Zenith project of The Netherlands Genomic Initiative (Project No. 93511033) and SCIEX. L.P. acknowledges the Spanish Ministry of Economy and Competitiveness for a FPI fellowship (BES-2012-061127) and a short stay fellowship (EEBB-I-16-11506). We thank Rob Haselberg for his input on the manuscript.
| Funders | Funder number |
|---|---|
| IBD-BIOM | |
| European Commission | |
| Seventh Framework Programme HighGlycan | |
| Marie Curie European Training Network | |
| Ministerio de Economía y Competitividad | RTI2018-097411-B-I00 |
| Seventh Framework Programme | 278535, 305479 |
| Horizon Programme Zenith project of The Netherlands Genomic Initiative | 93511033 |
| Horizon 2020 Framework Programme | 676421 |
| SCIEX | EEBB-I-16-11506, BES-2012-061127 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- bottom-up proteomics
- carcinoembryonic antigen
- CE-MS
- CEACAM5
- colorectal cancer
- glycomics
- glycopeptide
- glycosylation
Fingerprint
Dive into the research topics of 'Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis-Tandem Mass Spectrometry'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver